Cargando…
Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc), and there is no cure for it at present. We have previously reported that the tetramethylpyrazine (TMP) derivative T-006 exhibited...
Autores principales: | Zhou, Hefeng, Shao, Min, Yang, Xuanjun, Li, Chuwen, Cui, Guozhen, Gao, Cheng, Di, Lijun, Zhong, Hanbing, Wang, Yuqiang, Zhang, Zaijun, Lee, Simon Ming-Yuen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885178/ https://www.ncbi.nlm.nih.gov/pubmed/31827703 http://dx.doi.org/10.1155/2019/8169125 |
Ejemplares similares
-
Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways
por: Chen, Haiyun, et al.
Publicado: (2020) -
Oxyphylla A Promotes Degradation of α-Synuclein for Neuroprotection via Activation of Immunoproteasome
por: Zhou, Hefeng, et al.
Publicado: (2019) -
Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy
por: Zhang, Zaijun, et al.
Publicado: (2016) -
A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor
por: Hu, Shengquan, et al.
Publicado: (2018) -
Proteomic analysis reveals the potential neuroprotective effects of tetramethylpyrazine dimer in neuro2a/APPswe cells
por: Lin, Xiaoyi, et al.
Publicado: (2019)